IP Library Granted Patent US 11,935,626
Granted Patent B2
US 11,935,626 · App. 17/066,868 · Granted Mar 19, 2024

Methods for genome assembly and haplotype phasing

Inventors: Richard E. Green, Jr. (Santa Cruz, CA); Liana F. Lareau (San Francisco, CA)
Assignee: The Regents of the University of California
G16B30/20C12Q1/6874G16B30/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,935,626
App. No.
17/066,868
Granted
Mar 19, 2024
Kind
B2
Abstract

The disclosure provides methods to assemble genomes of eukaryotic or prokaryotic organisms. The disclosure further provides methods for haplotype phasing and meta-genomics assemblies.

Claims (22)

1. A method for haplotype phasing, the method comprising:

providing a cell comprising chromosomes;

crosslinking DNA within the chromosomes to form crosslinked DNA;

fragmenting the crosslinked DNA to form fragmented crosslinked DNA;

ligating two regions of the fragmented crosslinked DNA that are in close physical proximity to create ligated DNA comprising a ligation product, wherein the two regions comprise an intra-chromosomal pair;

shearing the ligated DNA to generate a plurality of smaller genomic fragments;

sequencing the plurality of smaller genomic fragments to generate sequencing reads;

identifying at least one heterozygous site in the sequencing reads; and

using the sequencing reads to determine haplotype phasing of the at least one heterozygous site.

2. The method of claim 1 , further comprising isolating the chromosomes before the crosslinking.

3. The method of claim 1 , further comprising purifying DNA prior to the sequencing.

4. The method of claim 3 , wherein the purifying comprises pulling down junction-containing fragments.

5. The method of claim 1 , further comprising, after the fragmenting, marking ends of the fragmented crosslinked DNA.

6. The method of claim 5 , wherein the marking comprises filling in ends of the fragmented crosslinked DNA with nucleotides comprising one or more markers.

7. The method of claim 6 , wherein the one or more markers are usable in a pull down.

8. The method of claim 7 , wherein the one or more markers comprise biotin.

9. The method of claim 1 , wherein the fragmenting comprises digesting the crosslinked DNA with a restriction enzyme.

10. The method of claim 1 , wherein the crosslinking comprises contacting DNA with formaldehyde.

11. The method of claim 1 , wherein the ligating comprises contacting the fragmented crosslinked DNA with a ligase.

12. The method of claim 1 , wherein the sequencing comprises paired-end sequencing.

13. The method of claim 1 , wherein the cell is a human cell.

14. The method of claim 1 , wherein the cell is diploid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2023
From: GREEN, RICHARD E., JR.; LAREAU, LIANA F.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 065088/0886 →
Continuity (5)
Continuation 15900723 · Feb 20, 2018
Continuation 15167880 · May 27, 2016
Continuation 14170339 · Jan 31, 2014
Provisional Application 61759941 · Feb 1, 2013
Related Publication 20210125687A1 · Apr 29, 2021
Cited By (4)
US 12,378,592 US 12,404,537 US 12,444,480 US 12,725,678